# Theoretical Model: Fractal Dimension → Pharmacokinetics

## 1. Foundation: Kopelman's Fractal Kinetics (1986, 1988)

### Classical vs Fractal Kinetics

In **homogeneous media**, reaction rate constants are time-independent:
```
-dC/dt = k × C^n
```

In **heterogeneous/fractal media**, rate "constants" become time-dependent:
```
-dC/dt = k(t) × C^n

where k(t) = k₀ × t^(-h)
```

### The Heterogeneity Exponent (h)

The exponent `h` captures the degree of spatial heterogeneity:
- **h = 0**: Homogeneous medium (classical kinetics)
- **h → 1**: Highly heterogeneous/fractal medium

Kopelman showed that `h` relates to the **spectral dimension** (d_s):
```
h = 1 - d_s/2
```

For a 2D system: d_s ≈ 2 × d_f / d_w

Where:
- d_f = fractal dimension of the substrate
- d_w = random walk dimension (~2 for normal diffusion)

## 2. Connection to Blood Microstructure

### Hypothesis

The fractal dimension measured from blood cell images (df_edge, df_distribution)
reflects the **heterogeneity of the blood microenvironment** that drugs experience
during distribution.

### Mapping Image df to Tissue Heterogeneity

```
df_edge (from image) → membrane complexity → permeability heterogeneity
df_distribution (from image) → cell spacing → diffusion path tortuosity
```

## 3. Proposed Model

### Step 1: Image → Fractal Metrics

From blood smear image, extract:
- `df_edge`: Fractal dimension of cell boundaries
- `df_dist`: Fractal dimension of cell spatial distribution
- `R`: Clustering index (Clark-Evans)

### Step 2: Fractal Metrics → Heterogeneity Exponent

**Proposed relationship:**
```
h = α × (2 - df_edge) + β × (2 - df_dist) + γ × |1 - R|

where:
- α, β, γ are empirically determined coefficients
- (2 - df_edge) captures deviation from space-filling (df = 2)
- (2 - df_dist) captures sparsity of cell distribution
- |1 - R| captures deviation from random distribution
```

**Simplified model (first approximation):**
```
h ≈ 2 - df_edge

Rationale: df_edge ∈ [1, 2] for cell boundaries
- df_edge = 2 (space-filling) → h = 0 (homogeneous)
- df_edge = 1 (simple line) → h = 1 (highly heterogeneous)
```

### Step 3: Heterogeneity Exponent → PK Parameters

From Jung et al. (2023) fractal PK models:

**Elimination rate constant:**
```
k_el(t) = k_el,0 × t^(-h)
```

**Effective clearance:**
```
CL_eff(t) = CL_0 × t^(-h)
```

**Fraction unbound (fu) - proposed:**
```
fu_eff = fu_intrinsic × (1 - h × binding_factor)

where binding_factor accounts for heterogeneous protein binding
```

## 4. Mathematical Framework

### Complete Model

Given:
- Blood smear image I
- Drug properties: logP, MW, pKa, fu_ref

Calculate:
```python
# Step 1: Extract fractal metrics
df_edge = box_counting(edge_detect(I))
df_dist = box_counting(cell_centroids(I))
R = clark_evans_index(cell_centroids(I))

# Step 2: Estimate heterogeneity exponent
h = model_h(df_edge, df_dist, R, drug_properties)

# Step 3: Predict PK parameters
k_el_fractal = k_el_pop × t^(-h)
CL_fractal = CL_pop × (1 + h × tissue_factor)
fu_pred = fu_ref × correction_factor(h)
```

### Correction Factor for fu

Based on heterogeneous binding theory:
```
correction_factor(h) = 1 / (1 + h × (1/fu_ref - 1) × α)

where α is an empirically determined constant (~0.1-0.5)
```

## 5. Validation Requirements

To validate this model, we need:

1. **Paired data**: Blood images + measured PK parameters from same subjects
2. **Multiple conditions**: Normal, pathological (e.g., sepsis, inflammation)
3. **Multiple drugs**: Different binding characteristics

### Proposed Validation Study

```
Subjects: N ≥ 50
Groups: 
  - Healthy controls (n=25)
  - Pathological condition (n=25)

For each subject:
  - Blood smear image → df_edge, df_dist, R
  - PK study → k_el, CL, Vd, fu

Analysis:
  - Correlate df metrics with PK parameters
  - Fit α, β, γ coefficients
  - Cross-validate predictions
```

## 6. Expected Outcomes

If the model is valid:

| Condition | df_edge | h | CL_fractal | Interpretation |
|-----------|---------|---|------------|----------------|
| Normal | ~1.7 | ~0.3 | ~CL_pop | Standard PK |
| Inflammation | ~1.5 | ~0.5 | ↑ CL | Faster elimination |
| Sepsis | ~1.3 | ~0.7 | ↑↑ CL | Much faster elimination |

## 7. Limitations and Caveats

1. **Blood smear ≠ in vivo blood**: Preparation artifacts
2. **2D image ≠ 3D tissue**: Projection effects
3. **Local vs systemic**: Image is local, PK is systemic
4. **Drug-specific**: Model may need drug class adjustments

## 8. References

- Kopelman R. (1986) J. Stat. Phys. 42:185-200
- Kopelman R. (1988) Science 241:1620-1626
- Jung et al. (2023) Pharmaceutics 15:304
- Pereira (2010) Comput. Math. Methods Med. 11:161-184

## Status

**THEORETICAL MODEL: COMPLETE**
**EMPIRICAL VALIDATION: PENDING**
**INTEGRATION STATUS: FUTURE FEATURE**

